Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

Characterization and Outcomes in Patients with SARS-CoV-2 Infection According to Body Mass Index

Laura J Ballen, Maria A Urbano, Guillermo E Guzman, Karen M Feriz, Veline Martínez

Objective: SARS-CoV-2 was declared a pandemic in 2020. Several factors related to severity and mortality have been described, including obesity. In Colombia, 56% of the population is over-weight/obese. We sought to investigate the characterization and outcomes of patients according to body mass index in a highly complex center in Colombia.

Methods: This is a prospective longitudinal observational descriptive study in patients older than 18 years treated at the Fundación Valle del Lili University Hospital in Cali, Colombia in 2020-2021, with a diagnosis of SARS-CoV-2 infection. Socio demographic characteristics, medical history, clinical presentation, paraclinical characteristics and outcomes were described.

Results: The average age was 48 years, 53% were men. 66.5% of the patients were overweight or obese. The severity of the disease according to the Body Mass Index (BMI) (p=0.011), days of stay in the ICU (p=0.0093), overall stay (p=0.0031), and duration of mechanical ventilation (p=0.0069) had relationships directly proportional to the increase in BMI. Nonetheless, our report does not allow to determine the association between mortality and obesity in patients with SARS-CoV-2 infection, since the differences found were not statistically significant (P=0.493).

Conclusion: Obesity is a risk factor for adverse outcomes and morbidity in SARS-CoV-2 infection. However, more studies are needed to explore additional factors according to the stage of the pandemic and advances in vaccination. We did not find an association with an increase in mortality in overweight and obese patients.